Clinical Trial Search

Primary: To Evaluate the Incidence of the Pre-proendothelin SNP at Nucleotide 5665 — 10 participants

Primary: Feasibility of Pacemaker Implant With Total Thoracoscopic Approach to Epicardial Pacing Lead — 100 percentage of particiapants

Primary: Mean Difference in Stroke Volume Between CMR and SMIC — 1.7 ml — p=0.47

Primary: Cardiac Index — 3.39; 3.42; 3.23 L/min/m2

Primary: Transition Readiness Assessment Questionnaire (TRAQ) Score — 2.77; 2.95; 3.80; 3.92 units on a scale

Primary: Feasibility Evaluation and Major Cardiac Adverse Events Related to Transcoronary Infusion of Cardiac Progenitor Cells — 0; 0 participants

Primary: BNP Levels — 16.3; 42.4; 384.3 pg/ml

Primary: Number of Incidence of Treatment Related Major Adverse Cardiac Events — 1; 0; 6 Events

Primary: Sensitivity of Color Doppler Examination to Detect Major Heart Defects During the Second Trimester of Pregnancy — 39; 9 fetuses

Primary: Proportion of Infants Who Are Intubated Prior to Umbilical Cord Clamping — 17 Participants

Primary: Moderate to Vigorous Physical Activity (MVPA) — -1.9; 3.4 average minutes per day — p=0.24

Primary: Comparison Between CASES and CONTROLS of the Occurrence of Specific Clinical Outcomes of Serious Infection, Serious Arrhythmia and/or Death — 303; 349 participants

Primary: Blood 25 Hydroxyvitamin D (25OHD) Concentrations — 34.8; 52.0 nmol/L

Primary: Composite Image Quality Score Among 7 Anatomical Structures. — 3.9; 2.7 score on a scale

Primary: Maximum Decline in Measured Cardiac Output — 0.68; 0.29 L/min/m2

Primary: Acetaminophen Serum Concentrations — 19; 17; 13; 13 mcg/mL

Primary: Recurrence of Advanced Heart Block — 5 Participants

Primary: Oxygenation Response — 4.2; 2.6 Change in Oxygenation Index

Primary: Coronary Flow Reserve (CFR) — 1.77 ratio: peak to baseline CFV

Primary: Proportion of Patients Who Died or Received a Heart Transplant — 100; 72 Participants — p=0.013

Primary: Freedom From Device or Procedure Related Death or Reintervention — 97.1 percentage of participants

Primary: Left Ventricular Mass Index — 67; 60 g/m2 — p=0.27

Primary: Changes in Hemodynamic Variables Recorded During Administration of Sevoflurane + Dexmedetomidine. — -0.14; -0.16; -0.21; 0.15 percentage of change from baseline — p=0.05

Primary: Number of Participants With Acute Kidney Injury — 18; 57 Participants

Primary: The Number of Graft Related Post-operative Complications That Require a Repeat Surgery or a Non Surgical Treatment Within 12-month Post Implantation. — 0 Participants

Primary: Number of Participants With Major Cardiac Adverse Events Related to Transcoronary Infusion of CDCs. — 1 Participants

Primary: Cardiac Glucose Uptake During Normoxic Rest (µg/Min) — 0.689; 0.540 µg/min — p=0.38

Primary: S-creatinine — 23.9; 25.9; 33.7; 34.2 μmol/L — p=0.45

Primary: Successful Repair of Conduit Disruption — 48 participants

Primary: Death, Heart Transplant, Left Ventricular Assist Device Implantation — 35 participants